Analyst firms · Evercore ISI · HCAT
Evercore ISI HCAT price target and rating history
Health Catalyst Inc (HCAT) · Technology
Evercore ISI rates Health Catalyst Inc (HCAT) In-line with a $11 price target, as of its latest action on Apr 9, 2025. It has published 3 rating actions on HCAT since January 2023, including 1 upgrade and 2 downgrades.
- Current rating
- In-line
- Price target
- $11
- Median target, all firms
- Too few
- Actions on HCAT
- 3
Evercore ISI price target on HCAT
Every Evercore ISI rating on HCAT
- Apr 9, 2025
- Jan 3, 2024
- Jan 3, 2023
How other firms rate HCAT
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Canaccord Genuity | Hold | $1.80 | Aug 21, 2026 |
| Wells Fargo | Equal Weight | $1 | Mar 18, 2026 |
Questions about Evercore ISI and HCAT
- What is Evercore ISI's price target for HCAT?
- Evercore ISI's latest stated price target for Health Catalyst Inc (HCAT) is $11, from its action on Jan 3, 2024.
- What is Evercore ISI's rating on HCAT?
- Evercore ISI rates HCAT In-line, a neutral rating, as of Apr 9, 2025.
- When did Evercore ISI last change its view on HCAT?
- On Apr 9, 2025, Evercore ISI downgrades to In-line from Outperform.
More HCAT rating histories
All Evercore ISI ratingsHCAT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.